A new haemodialysis catheter-locking agent reduces infections in haemodialysis patients

Journal of Renal Care

Volumn 34, Issue 3, 2008, Pages 116-120

  Taylor, Caroline ^a   Cahill, John ^b   Gerrish, Martin ^a   Little, Jane ^a  

^a LINCOLN COUNTY HOSPITAL   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Antibiotics; Haemodialysis; Hospitalisation; Infection; Intravenous catheter; Taurolidine citrate

Indexed keywords

DRUG DERIVATIVE; TAURINE; TAUROLIDINE; THIADIAZINE DERIVATIVE; TOPICAL ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; CHI SQUARE DISTRIBUTION; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST OF ILLNESS; CROSS INFECTION; CROSSOVER PROCEDURE; ECONOMICS; EQUIPMENT; EQUIPMENT DESIGN; FEMALE; HUMAN; INCIDENCE; INDWELLING CATHETER; INFECTION CONTROL; INSTRUMENTATION; LAVAGE; MALE; METHODOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; SEPSIS; STATISTICAL MODEL; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS, LOCAL; CATHETERS, INDWELLING; CHI-SQUARE DISTRIBUTION; COST OF ILLNESS; CROSS INFECTION; CROSS-OVER STUDIES; ENGLAND; EQUIPMENT CONTAMINATION; EQUIPMENT DESIGN; FEMALE; HUMANS; INCIDENCE; INFECTION CONTROL; IRRIGATION; KIDNEY FAILURE, CHRONIC; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; RENAL DIALYSIS; SEPSIS; TAURINE; THIADIAZINES;

EID: 50449096050     PISSN: 17556678     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1755-6686.2008.00027.x     Document Type: Article

References (20)

1. Allon M. (2003). Propylaxis against dialysis catheter-related bacteremia with a novel antimirobial lock solution. Clinical Infectious Diseases 36(12), 1539-1544.
2. Anthony T. & Rubin L. (1999). Stability of antibiotics used for antibiotic-lock treatment of infections of implantable venous devices. Antimicrobial Agents and Chemotherapy 43(8), 2074-2076.
3. Beathard G. (1999). Management of bacteraemia associated with tunnelled-cuffed haemodialysis catheters. Journal of the American Society of Nephrology 10, 1045-1049.
4. Betjes M.G. & van Agteren M. (2004) Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. Nephrology Dialysis Transplantation 19(6), 1546-1551.
5. Department of Health. (2004). The National Service Framework for renal services, part one: dialysis and transplantation. London: Department of Health.
6. Haimi-Cohen Y., Husain N., Meenan J. et al. (2001). Simplifying treatment of port-associated bloodstream infections by using the antibiotic lock technique. The American Society of Microbiolgy 45(5), 1565-1567.
7. Jean G., Charra B., Chazot C. et al. (2002). Risk factor analysis for long-term tunneled dialysis catheter-related bacteremias. Nephron 91(3), 399-405;
8. Jean G., Charra B., Chazot C. et al. Journal of the Pakistan Medical Association 54(8), 408-412.
9. Kim S.H., Song K.I., Chang J.W. et al. (2006). Prevention of uncuffed hemodialysis catheter-related bacteremia using an antibiotic lock technique: a prospective, randomised clinical trial. Kidney International 69(1), 161-164.
10. Krishnasami Z., Cotton D., Bimbo L. et al. (2002). Management of haemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution. Kidney international 61, 1136-1142.
11. Lee S.C., Chen K.S., Tsai C.J. et al. (2004). An outbreak of methicillin-resistant Staphylococcus aureus infections related to central venous catheters for haemodialysis. Infection Control and Hospital Epidemiology 25(8), 678-684.
12. Mailloux L.U., Bellucci A.G., Wilkes B.M. et al. (1991). Mortality in dialysis patients: analysis of the causes of death. American Journal of Kidney Diseases 18, 326-335.
13. McDonald L.C., Banerjee S.N. & Jarvis W.R. (1999). Seasonal variation of Acinetobacter infection: 1987-1996. Clinical Infectious Diseases 29(5), 1133-1137.
14. Moro M.L., Vigano E.F. & Cozzi L.A. (1994). Risk factors for central venous catheter-related infections in surgical and intensive care unit. Infection Control and Hospital Epidemiology 15(4 Pt 1), 253-264.
15. Nagashima G., Kikuchi T., Tsuyuzaki H. et al. (2006). To reduce catheter-related bloodstream infections: is the subdavian route better than the jugular route for central venous catheterization? Journal of Infection and Chemotherapy 12(6), 363-365.
16. Pawar M., Mehta Y., Kapoor P. et al. (2004). Central venous catheter-related blood stream infections: incidence, risk factors, outcome, and associated pathogens. Journal of Cardiothoracic and Vascular Anesthesia 18(3), 304-308.
17. Pisoni R.L., Young E.W., Dykstra D.M. et al. (2002). Vascular access use in Europe and the United States: results from the DOPPS. Kidney International 61(1), 305-316.
18. Saad T.F. (1999). Bacteraemia associated with tunneled, cuffed haemodialysis catheters. American Journal of Kidney Diseases 34, 1114-1124.
19. Taurolock ®, Kimal Ag. (2005). Data on file: obtained December 2005.
20. UK Renal Registry. (2006). UK Renal Registry Report 2006. Bristol: UK Renal Registry.